Modular Medical (MODD) Insider Morgan Frank Buys 312 Shares

On June 30, 2026, Morgan Frank purchased 312 shares of MODD, reflecting an active interest in the company. The transaction was not part of a pre-planned trading program, and the specific purchase price wasn't disclosed. MODD shares traded at $4.41 on Wednesday.

Other Institutional Activity in MODD

Several institutional investors have recently adjusted their positions in MODD. AWM Investment Company, Inc. opened a new position with 12,222 shares worth about $1,935,996. In contrast, Solas Capital Management dramatically reduced its holdings by 4,414,456 shares, now holding 9,603 shares valued at approximately $1,521,142, marking a 99.8% decrease. Similarly, Bleichroeder LP cut its stake by 2,853,348 shares, ending with 6,233 shares valued at $987,286, also a 99.8% decrease. Vanguard Capital Management LLC initiated a new position with 1,864 shares, valued at around $295,242.

Insider Buying and Selling at Modular Medical, Inc.

Several insiders have been active in trading MODD shares. On June 30, 2026, Frank Morgan acquired 312 shares. Previously, on May 14, 2026, Kevin Schmid, the Chief Operating Officer, bought 4,674 shares, and Paul DiPerna, the Chairman, President, Chief Financial Officer, and Treasurer, purchased 11,218 shares, both at no cost per share. Earlier, on March 31, 2026, Frank Morgan had also acquired 312 shares, and Philip Brent Sheibley bought 250 shares.

Analysts Set New Price Targets

Analysts continue to show interest in MODD. On September 19, 2023, Oppenheimer maintained its buy rating with a price target of $3.5. Similarly, Benchmark Co. upheld its buy rating on January 30, 2023, with a target price of $5.0. The consensus among analysts remains positive, reflecting confidence in the stock's potential.

Bottom Line

Morgan Frank's recent purchase of MODD shares indicates a personal investment interest. Institutional investors have shown mixed actions, with some significantly reducing their stakes. Analysts maintain a positive outlook on the stock, suggesting potential for future growth. As always, these insider and institutional activities provide a snapshot of interest but may not reflect current positions due to the timing of disclosures.